Breast Cancer: Feasibility of an Educational Intervention
NCT ID: NCT04396665
Last Updated: 2021-08-20
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
224 participants
INTERVENTIONAL
2019-12-01
2020-11-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Design: pilot test Population: 300 women without breast cancer living in Asturias. 25 to 50 years old. Informed consent signed.
Variables: personal characteristics (age, status, educational level, occupation), MIC index, dietary characteristics, level of physical activity, presence of known risks of breast cancer (number of children, breastfeeding, oral contraceptives, family history of cancer, previous cancer, breast density and knowledge related with breast cancer prevention.
Intervention:
* Intervention Group:6 months intervention using a web-app related with personal care and breast cancer risks, diet and physical activity.
* Control Group: no intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Project Breast47: Effect of an Educational Intervention
NCT05267171
Evaluation of Attitudes About Fertility
NCT01705561
Impact of Pre-Operative Web-based Breast Cancer Information on the Quality of Patient Decision-Making
NCT03116035
Individualized Risk-Based Education in Promoting Breast Cancer Screening in Healthy Women
NCT00416975
Culturally-Informed Counseling in Latinas at High Risk for Hereditary Breast or Ovarian Cancer
NCT01230346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Design: pilot test Population: 300 women without breast cancer living in Asturias. 25 to 50 years old. They are recluted for a previous study developed by the same research team. An information document and a written consent was given for the women. Those who signed the consent are included.
The randomization for intervention or control group are doing based on the where the city where the women home is located. the objective of this distribution is to avoid contact between women from different groups.
Variables: personal characteristics (age, status, educational level, civil status), MIC index, dietary characteristics, level of physical activity, knowledge related with breast cancer symptoms and risk factors.
Intervention:
The 6 months intervention are going to be developed using a web-app. The intervention is based on the Behavior Change Wheel model. Capacity and motivation are going to be the determinants on which it will work using for it interventions based on education, persuasion and modeling among others.
Intervention Group: 6 months intervention using a web-app related. The web-app includes some sections:
* Information related with breast cancer risk.
* Breast self examination. Written text and videos done by a nurse.
* Physical exercise. Written text and videos done by a physiotherapist .
* Dietary information. Written text and videos done by a nutrition expert.
The Control Group are not going to receive intervention during the study period time. After that, women are going to be access to the web-app.
Statistical analysis
Descriptive statistics will be carried out (means, standard deviation, CI and percentages). In addition, at the end of the study, in order to determine the factibility of the educational intervention, the variation of the intra-group data (from pre to psot-test) and between the groups in post-test will be compared using the chi-square test. , t-student or Mann-Whitney U, for qualitative or quantitative data respectively.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Precam Group (Intervention Group)
150 Women without breast cancer, aged from 25 to 50 years old
Precam
6 months Web-App intervention related with: diet, physical activity, self-care and breast cacner risk prevention
Control Group
150 Women without breast cancer, aged from 25 to 50 years old
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Precam
6 months Web-App intervention related with: diet, physical activity, self-care and breast cacner risk prevention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Capability to use internet
Exclusion Criteria
25 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oviedo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rubén Martín Payo
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ruben Martin Payo, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Oviedo
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Oviedo
Oviedo, Principality of Asturias, Spain
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
147/19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.